Home » Topics » Regulatory » Patents

Patents
RSS

Dainippon reports anti-H. pylori compounds

April 26, 1996

EPC-K for pancreatitis

April 26, 1996

Byk Gulden claims agents for H. pylori control

April 26, 1996

Enadoline claimed for treatment of BPH

April 26, 1996

5alpha-Reductase inhibitors for BPH disclosed by Lilly

April 26, 1996

SR-48692 claimed for use as diuretic

April 26, 1996

NOS inhibitors claimed by Ono

April 26, 1996

Antirestenosis agents reported by Fujisawa, Teijin

April 26, 1996

ACE/NEP inhibitors claimed by Fujisawa

April 26, 1996

New Glaxo Wellcome compounds protect against leukocyte-induced tissue damage

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 11, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 11, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.